Navigation Links
Cell Therapeutics Reports 76% Decrease in First Quarter 2009 Net Loss Attributable to Common Shareholders; Completion of Pixantrone NDA Submission on Track for Second Quarter 2009
Date:5/6/2009

-- -- Total revenues 20 3,394 -- ----- Operating expenses, net: Cost of product sold - 890 Research and development 7,956 15,855 Selling, general and administrative 8,874 11,210 Amortization of purchased intangibles - 397 Gain on sale of Zevalin (10,244) - ------- --- Total operating expenses, net 6,586 28,352 ----- ------ Loss from operations (6,566) (24,958) Other income (expense): Investment and other income, net 34 260 Interest expense (1,617) (1,985) Amortization of debt discount and issuance costs (4,851) (10,944) Foreign exchange gain (loss) 41 (2,237) Make-whole interest expense (6,345) (7,781) Gain on derivative liabilities, net 5,622 11,744 Loss on exchange of convertible notes - (2,295) Equity loss from investment in joint venture (1,204) - Settlement expense (170) - ---- --- Net loss before noncontrolling interest (15,056) (38,196) Noncontrolling interest 89 32 -- -- Net loss attributable to CTI (14,967) (38,164) Gain on restructuring of preferred stock 2,116 - Preferred stock dividends
'/>"/>
SOURCE Cell Therapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. Oxygen Biotherapeutics, Inc. Files Cosmetic Product Ingredient Statement for new Oxycyte-based Cosmetic Gel
2. Royer Animal Health Enters Into Exclusive Agreement With MWI Veterinary Supply for U.S. Distribution of Next-Generation Therapeutics to Treat Cancer and Infections
3. Cornerstone Therapeutics to Host First Quarter 2009 Conference Call
4. Prime Therapeutics Announces Departure of President and Chief Executive Officer Timothy Dickman
5. InteRNA Technologies and Radboud University Nijmegen Medical Centre to Develop microRNA-based Therapeutics for Prostate Cancer
6. Tolera Therapeutics Granted Orphan Drug Designation for Organ Transplant Rejection Drug
7. TorreyPines Therapeutics, Inc. Hires Advisor to Evaluate Strategic Alternatives
8. Sirion Therapeutics Announces Positive Results From Interim Analysis of Phase II Trial and Receives FDA Fast Track Designation for Fenretinide
9. Intrinsic Therapeutics Announces CE Mark for Barricaid Anular Prosthesis
10. Cell Therapeutics Initiating Rolling NDA Submission for Pixantrone
11. Former Executive at Genzyme Corp. and Osiris Therapeutics, Inc. to Head Business Advisory Board at Rx for Africa, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... its top dressmaking technologies, has been a leading dress supplier ... latest designs of wedding dresses and launching a site-wide promotion ... the fresh new products are designed for 2015, and they ... All the clothes from LunaDress follow up with the latest ...
(Date:1/22/2015)... VogueQueen is a seasoned and trusted leader who ... are thrilled to have it lead the wedding dress industry ... of prom dresses for the global market. , “The CEO ... and he focuses on continuing the goal of operational excellence ...
(Date:1/22/2015)... 2015 The federal court overseeing thousands of ... Court, Southern District of West Virginia has upheld a $2 ... first bellwether trial. In an Order dated January 21st, the ... finding that C.R. Bard had not proven a miscarriage of ...
(Date:1/22/2015)... For over 20 years, Dr. David Cruz of ... area has treated just about every type of injury that ... And for those same twenty-plus years, the team at Doctors ... with the best possible doctor. With the combined breadth ...
(Date:1/22/2015)... has added many trendy Champagne wedding dresses to ... the past three years. Today, the business announces a special ... the sales manager of the company, this is on the ... point can be reflected on the discounted wedding dresses from ...
Breaking Medicine News(10 mins):Health News:LunaDress Shows The Latest Styles Of Wedding Dresses In 2015 2Health News:VogueQueen Unveils New Designs of Prom Dresses for 2015 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 3Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 4Health News:Industry Leading Chiropractor in Oceanside Joins the Doctors on Liens Network 2Health News:Weddingshe Announces A Special Offer On Its Popular Glamorous Wedding Dresses 2
... to use Entrust grid cards, tokens and one-time-passcodes for ... June 23 Healthcare networks and facilities rely on ... that have access to it. Importantly, this is no ... to make it possible. In fact, Entrust, Inc. (Nasdaq: ...
... ... and team effort , ... (Vocus) June 23, 2009 -- CHRISTUS St. Vincent Regional Medical Center and CHRISTUS St. Vincent ... leadership, achieved a $1.8 million supply chain savings in nine months. CHRISTUS ...
... Texas, June 23 Go Healthy, Inc. (Pink Sheets: GOHE) ... with a business development firm. The firm, Lonnie T. ... and expertise with vast connections and relations developed during his ... Morgan believes GO HEALTHY products are vital to addressing ...
... the critical issues of health ingredients and food safety , ... today and the food ingredients industry will be there. After ... will once again run alongside Health ingredients (Hi) and Natural ingredients ... 2009 in Shanghai, China. , , Ingredients ...
... Interaction ... case study about how its innovative HR transformation process helped the world,s largest manufacturer of ... , ... 23, 2009 -- Interaction Associates (IA) - a 40-year consultancy with a focus on collaboration ...
... ... on Heat Sinks market. A robust electronics sector and rapid development in technology with increased ... and Europe are among the key regions, while emerging markets such as Asia Pacific and ... ...
Cached Medicine News:Health News:Austrian IT Solutions Provider x-tention IT GmbH Implements Entrust Versatile Authentication Platform 2Health News:Austrian IT Solutions Provider x-tention IT GmbH Implements Entrust Versatile Authentication Platform 3Health News:CHRISTUS Health New Mexico Region Focuses on Cost Management; Saves $1.8 Million 2Health News:CHRISTUS Health New Mexico Region Focuses on Cost Management; Saves $1.8 Million 3Health News:Go Healthy Announces Association With Business Development Firm 2Health News:Opening Day of Fi Asia-China 2009 Brings the Food Ingredients Industry to Shanghai 2Health News:Opening Day of Fi Asia-China 2009 Brings the Food Ingredients Industry to Shanghai 3Health News:Transforming the HR Function Into Strategic Partner at World's Largest Medical Device Company 2Health News:Heat Sinks Market to Reach $2.64 Billion by 2015, According to New Report by Global Industry Analysts, Inc. 2Health News:Heat Sinks Market to Reach $2.64 Billion by 2015, According to New Report by Global Industry Analysts, Inc. 3
(Date:1/23/2015)... N.C. , Jan. 23, 2015 For the pharmaceutical ... in dealing with payers. Likewise, the importance of the managed ... will only continue to grow as payer formularies and provider ... therapies. At the same time, managed markets leaders ...
(Date:1/23/2015)... Jan. 23, 2015 A lot of discussion in the ... treating  certain illnesses, injuries, or conditions. As medical science advances, ... methods with ones that they consider to be more cutting ... not one textbook method of treatment that stands out as ...
(Date:1/23/2015)... Jan. 23, 2015  A new analysis of Centers for ... enrollment data shows that 81 percent of seniors chose ... extra discounts at certain pharmacies. The findings were released ... plans are now the foundation of Medicare Part D," ...
Breaking Medicine Technology:As Payer Influence Rises, Pharmaceutical Companies work to Optimize the Managed Markets Function 2No One-Size-Fits-All Remedy for Hernia Correction 2New Analysis: 81 Percent of Medicare Part D Seniors Choose "Preferred Pharmacy" Plans in 2015 2
... Primates Containing 1,000-Times the Dosage Recommended for Humans Shows ... Potential for Weekly or Bi-Monthly Dosing Frequency -NES-ZIONA, Israel, ... today reported results from a pilot toxicity study in ... long-acting human growth hormone (hGH), as well as to ...
... scientists, findings in ataxia telangiectasia-like disease and ... links between brain disease and cancer vulnerability ... 14 Scientists at St. ... the biological details distinguishing two related neurological ...
Cached Medicine Technology:Modigene Announces Positive Results of Pilot Toxicity Study of Its Long-Acting Human Growth Hormone hGH-CTP 2Modigene Announces Positive Results of Pilot Toxicity Study of Its Long-Acting Human Growth Hormone hGH-CTP 3Modigene Announces Positive Results of Pilot Toxicity Study of Its Long-Acting Human Growth Hormone hGH-CTP 4Study Shows How Defective DNA Repair Triggers Two Neurological Diseases 2Study Shows How Defective DNA Repair Triggers Two Neurological Diseases 3
... (DAI) ENA Profile Enzyme-Linked Immunosorbent Assay (ELISA) ... in human serum to individually coated Smith, ... Jo-1 in a single serum specimen. The ... used as an aid in the diagnosis ...
... an enzyme immunoassay(EIA) test system for ... nuclear antigens Sm, RNP, SSA, SSB, ... The results from this assay can ... the diagnosis of autoimmune disease. This ...
... Single Well Screening Kit is designed to screen ... autoantibodies. Each microtiter well is coated with Sm, ... allows the laboratory to cost effectively screen out ... the ENA specificity on any of the company's ...
The K-ASSAY® D-Dimer Control set is intended to be used a consistent test sample of known concentration for monitoring the performance of D-Dimer immunoturbidimetric assays....
Medicine Products: